THRM - ジェンサ―ム (Gentherm Inc) ジェンサ―ム

 THRMのチャート


 THRMの企業情報

symbol THRM
会社名 Gentherm Inc (ジェンサ―ム)
分野(sector) Capital Goods   資本財(工業製品)
産業(industry) Auto Parts:O.E.M.  
業種 自動車_トラック_自動二輪車部品   一般消費財(Consumer Products)
概要 事業概要 ジェンサーム(Gentherm Incorporated)は、熱管理技術の設計・開発・製造に従事するグローバル技術会社である。同社は自動車と工業の2つの事業を運営する。同社の製品は、乗用車の快適性と利便性、バッテリ温度管理、遠隔発電、患者温度管理、環境製品試験、その他の消費者および産業用温度制御のニーズに対応するソリューションを提供する。同社の自動車製品は、北米、欧州、アジアで営業している主要自動車メーカーの車両に搭載される。自動車事業は、グローバルな自動車事業および個別のコンビニエンス商品の成果を含む。工業事業は遠隔発電システム事業、患者温度管理システム事業、環境試験機器およびサービス事業、高度な研究および製品開発部門の複合的な結果を含む。   ジェンサ―ムは米国の自動車部品メ―カ―。冷暖房・換気装置の設計、開発、製造を手がける、主力商品はカ―シ―トヒ―タ― ・カ―シ―トク―ラ― ・カップホ―ルダ―ヒ―タ― ・カップホ―ルダ―ク―ラ― ・ハンドルヒ―タ―.等の自動車シ―ト部品。本社はミシガン州ノ―スビル。   Gentherm is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery performance solutions, cable systems and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 11,000 employees in facilities in the United States, Germany, Canada, China, Hungary, Japan, Korea, North Macedonia, Malta, Mexico, United Kingdom, Ukraine, and Vietnam.
本社所在地 21680 Haggerty Road Northville MI 48167 USA
代表者氏名 Francois J. Castaing フランソワ・J・キャスティング
代表者役職名 Lead Independent Chairman of the Board
電話番号 +1 248-504-0500
設立年月日 33329
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 13069人
url www.gentherm.com
nasdaq_url https://www.nasdaq.com/symbol/thrm
adr_tso
EBITDA EBITDA(百万ドル) 130.96700
終値(lastsale) 43.69
時価総額(marketcap) 1593064363.14
時価総額 時価総額(百万ドル) 1412.938
売上高 売上高(百万ドル) 118.706
企業価値(EV) 企業価値(EV)(百万ドル) 1460.481
当期純利益 当期純利益(百万ドル) 51.09000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Gentherm Inc revenues increased 7% to $525.7M. Net income decreased 13% to $29.6M. Revenues reflect Automative segment increase of 10% to $480.8M Germany segment increase of 29% to $46M United States segment increase of 4% to $243.9M China segment increase of 22% to $49.1M. Net income was offset by Automative segment income decrease of 14% to $78.5M Industrial segment loss increase from $5.1M to $14.7M.

 THRMのテクニカル分析


 THRMのニュース

   Femtech Market Report (2021-2028), Business Plan Strategy, New Solutions, Key Segments, Potential Targets and Recommendations | Gentherm, Drägerwerk, Ecolab, Geratherm Medical, ZOLL Medical  2021/06/21 20:26:31 OpenPR
Femtech is a combination of words female and technology. It is widely used for a category of software, diagnostics, products, and services, which are used for women''s health. This segment''s range of products and services includes fertility solutions, women''s reproductive
   Temperature Management Systems Market Report (2021-2028), Business Plan Strategy, New Solutions, Key Segments, Potential Targets and Recommendations | Gentherm, Drägerwerk, Ecolab, Geratherm Medical, ZOLL Medical  2021/06/21 18:42:05 OpenPR
Temperature Management Systems, called thermal management systems, utilizes heat transfer and thermodynamics to manage the temperature of a system. Temperature management systems aid in regulating and maintaining the normal body temperature of patients in intensive care, resting rooms, OT''s, and
   Therma Bright Reports Performance of Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test from Brazilian Clinical Study  2021/06/18 00:06:15 IT Business Net
Toronto, Ontario(Newsfile Corp. June 17, 2021) Therma Bright Inc. (TSXV: THRM) (Therma or The post Therma Bright Reports Performance of Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test from Brazilian Clinical Study first appeared on IT Business Net .
   Therma Bright (TSXV:THRM) Updates on AcuVid COVID-19 Brazilian Clinical Study  2021/06/17 22:30:00 The Market Herald
Therma Bright (THRM) has announced results from its ongoing its AcuVid COVID-19 The post Therma Bright (TSXV:THRM) Updates on AcuVid COVID-19 Brazilian Clinical Study appeared first on The Market Herald .
   Therma Bright Inc.: Therma Bright Reports Performance of Its AcuVid COVID-19 Rapid Antigen Saliva Test from Brazilian Clinical Study  2021/06/17 21:21:00 FinanzNachrichten
Toronto, Ontario--(Newsfile Corp. - June 17, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and a progressive medic
   Gentherm Pops 8% On Optimistic 2021 Revenue Outlook, 4Q Beat  2021/03/02 14:21:19 Smarter Analyst
Shares of Gentherm rose 8.3% on Monday after delivering better-than-expected earnings and revenues for the fourth quarter. The post Gentherm Pops 8% On Optimistic 2021 Revenue Outlook, 4Q Beat appeared first on Smarter Analyst .
   Gentherm: Q4 Earnings Insights  2021/03/01 07:08:00 Benzinga
Shares of Gentherm (NASDAQ:THRM) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 78.46% over the …
   Earnings Preview for Gentherm  2021/02/26 10:07:00 Benzinga
Gentherm (NASDAQ:THRM) releases its next round of earnings this Monday, March 01. Here is Benzinga's essential guide to Gentherm's Q4 earnings …
   Therma Bright Improves COVID-19 Rapid Saliva Antigen Test To 86% Sensitivity, 100% Specificity  2021/01/18 21:22:30 The Deep Dive
Therma Bright Inc (TSXV: THRM) this afternoon halted its equity from trading for the dying minutes of the days session
   Temperature Modulation Devices Market 2020 to 2027| Stryker, GENTHERM, Belmont Instrument, LLC, KCWW, 3M, Mennen Medical Ltd., Smiths Group plc  2020/11/03 19:16:57 OpenPR
Temperature modulation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and
   Gentherm Pops 8% On Optimistic 2021 Revenue Outlook, 4Q Beat  2021/03/02 14:21:19 Smarter Analyst
Shares of Gentherm rose 8.3% on Monday after delivering better-than-expected earnings and revenues for the fourth quarter. The post Gentherm Pops 8% On Optimistic 2021 Revenue Outlook, 4Q Beat appeared first on Smarter Analyst .
   Gentherm: Q4 Earnings Insights  2021/03/01 07:08:00 Benzinga
Shares of Gentherm (NASDAQ:THRM) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 78.46% over the …
   Earnings Preview for Gentherm  2021/02/26 10:07:00 Benzinga
Gentherm (NASDAQ:THRM) releases its next round of earnings this Monday, March 01. Here is Benzinga's essential guide to Gentherm's Q4 earnings …
   Therma Bright Improves COVID-19 Rapid Saliva Antigen Test To 86% Sensitivity, 100% Specificity  2021/01/18 21:22:30 The Deep Dive
Therma Bright Inc (TSXV: THRM) this afternoon halted its equity from trading for the dying minutes of the days session
   Temperature Modulation Devices Market 2020 to 2027| Stryker, GENTHERM, Belmont Instrument, LLC, KCWW, 3M, Mennen Medical Ltd., Smiths Group plc  2020/11/03 19:16:57 OpenPR
Temperature modulation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and

 関連キーワード  (自動車_トラック_自動二輪車部品 米国株 ジェンサ―ム THRM Gentherm Inc)

 twitter  (公式ツイッターやCEOツイッターなど)